FIQDX | HBLRX | FIQDX / HBLRX | |
Total Expense Ratio | 0.61 | 1.28 | 48% |
Annual Report Gross Expense Ratio | 0.67 | 1.28 | 52% |
Fund Existence | 7 years | 15 years | - |
Gain YTD | 1.652 | 1.481 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 488M | 11.7B | 4% |
Annual Yield % from dividends | 4.83 | 2.99 | 162% |
Returns for 1 year | 5.13 | 2.44 | 211% |
Returns for 3 years | 9.27 | 7.90 | 117% |
Returns for 5 years | 46.71 | 16.20 | 288% |
Returns for 10 years | N/A | 28.50 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 40.16 | 0.32 | +0.80% |
SPDR® S&P Pharmaceuticals ETF | |||
QGRO | 100.26 | 0.54 | +0.54% |
American Century US Quality Growth ETF | |||
RZB | 24.98 | 0.13 | +0.52% |
Reinsurance Group of America | |||
DFSE | 34.48 | -0.04 | -0.12% |
Dimensional Emerging Mrkts Sstby Cr 1ETF | |||
SHAG | 47.51 | -0.10 | -0.20% |
WisdomTree Yield Enh US S-T Aggt Bd ETF |